D. Bailey

发表

Phase I evaluation of carboplatin by use of a dosing strategy based on a targeted area under the platinum concentration-versus-time curve and individual glomerular filtration rate in cats with tumors.

L. Pendyala, N. Dykes, K. Rassnick, 2009, American journal of veterinary research.

Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer.

L. Lewis, M. Mcentee, M. Kiselow, 2014, Veterinary and comparative oncology.

Effect of glomerular filtration rate on clearance and myelotoxicity of carboplatin in cats with tumors.

P. J. Hoopes, H. Erb, R. Page, 2004, American journal of veterinary research.

Diagnostic evaluation and treatment recommendations for dogs with substage-a high-grade multicentric lymphoma: results of a survey of veterinarians.

D. Bailey, R. Regan, M. S. Kaplan, 2013, Veterinary and comparative oncology.

Phase I dose escalation of single-agent vinblastine in dogs.

K. Rassnick, C. Balkman, J. Chretin, 2008, Journal of veterinary internal medicine.

Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.

H. Erb, M. Hauck, L. Williams, 2003, Journal of veterinary internal medicine.

Determination of strong ion gap in healthy dogs.

D. Bailey, Pamela K Fettig, Kristi M Gannon, 2012, Journal of veterinary emergency and critical care.

Evaluation of serum iohexol clearance for use in predicting carboplatin clearance in cats.

N. Dykes, K. Rassnick, D. Bailey, 2009, American journal of veterinary research.

A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.

D. Russell, M. Kiselow, K. Rassnick, 2010, Veterinary and comparative oncology.

Efficacy of vinblastine for treatment of canine mast cell tumors.

M. Kiselow, K. Rassnick, A. Flory, 2008, Journal of veterinary internal medicine.

Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.

N. Northrup, A. Moore, K. Rassnick, 2009, Journal of veterinary internal medicine.

Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.

L. L. Barlow, M. Kiselow, K. Rassnick, 2010, Veterinary and comparative oncology.

Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs.

R. Al-Sarraf, K. Rassnick, J. Chretin, 2010, Veterinary and comparative oncology.

TREATMENT RECOMMENDATIONS FOR CANINE MAST CELL TUMORS

D. Bailey, 2014 .

Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study

M. Pennell, D. Thamm, C. London, 2015, PloS one.

Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).

Jonathan M. Miller, S. Brenn, D. Bailey, 2018, Journal of the American Veterinary Medical Association.

Nuclear morphologic and morphometric analyses of nodular poorly differentiated lymphocytic lymphoma: assessment of small cleaved nuclei.

I. Dardick, D. Bailey, M. Jeans, 1985, Human pathology.

Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma.

N. Northrup, A. Moore, D. Russell, 2010, Journal of veterinary internal medicine.

Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.

R. Al-Sarraf, M. Kiselow, K. Rassnick, 2008, Journal of veterinary internal medicine.

Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.

M. Kiselow, K. Rassnick, E. Malone, 2014, Journal of the American Animal Hospital Association.

Evaluation of dexamethasone as a chemoprotectant for CCNU-induced bone marrow suppression in dogs.

J. Wakshlag, R. Al-Sarraf, M. Kiselow, 2009, Veterinary and comparative oncology.

Survival time for dogs with previously untreated, peripheral nodal, intermediate- or large-cell lymphoma treated with prednisone alone: the Canine Lymphoma Steroid Only trial.

D. Kamstock, Margaret L. Musser, M. Kiselow, 2021, Journal of the American Veterinary Medical Association.

Comparison of first-opinion and second-opinion histopathology from dogs and cats with cancer: 430 cases (2001-2008).

S. McDonough, K. Rassnick, C. Balkman, 2010, Veterinary and comparative oncology.

Esophageal foreign bodies in dogs: 34 cases (2004-2009).

D. Bailey, Sean R Freer, Kristi M Gannon, 2012, Journal of veterinary emergency and critical care.

Chapter 24 – Tumors of the Endocrine System

R. Page, D. Bailey, 2007 .

Shock index is associated with mortality in canine vehicular trauma patients.

D. Bailey, Pamela K Fettig, Y. Cortes, 2020, Journal of veterinary emergency and critical care.

Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs

D. Trump, Candace S. Johnson, K. Rassnick, 2010, Cancer Chemotherapy and Pharmacology.

Phase I dose escalation of single-agent vinblastine in dogs.

K. Rassnick, C. Balkman, J. Chretin, 2008, Journal of veterinary internal medicine.

Comparison of two questionnaires to assess gastrointestinal toxicity in dogs and cats treated with chemotherapy*.

M. Kiselow, K. Rassnick, E. Malone, 2011, Veterinary and comparative oncology.